ES537104A0 - Un procedimiento para preparar derivados de tiazina - Google Patents

Un procedimiento para preparar derivados de tiazina

Info

Publication number
ES537104A0
ES537104A0 ES537104A ES537104A ES537104A0 ES 537104 A0 ES537104 A0 ES 537104A0 ES 537104 A ES537104 A ES 537104A ES 537104 A ES537104 A ES 537104A ES 537104 A0 ES537104 A0 ES 537104A0
Authority
ES
Spain
Prior art keywords
tiazine
derivatives
preparing
procedure
tiazine derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES537104A
Other languages
English (en)
Other versions
ES8606304A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of ES8606304A1 publication Critical patent/ES8606304A1/es
Publication of ES537104A0 publication Critical patent/ES537104A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075—Two hetero atoms, in positions 3 and 5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ES537104A 1983-10-27 1984-10-26 Un procedimiento para preparar derivados de tiazina Expired ES8606304A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838328757A GB8328757D0 (en) 1983-10-27 1983-10-27 Chemical compounds

Publications (2)

Publication Number Publication Date
ES8606304A1 ES8606304A1 (es) 1986-04-16
ES537104A0 true ES537104A0 (es) 1986-04-16

Family

ID=10550834

Family Applications (1)

Application Number Title Priority Date Filing Date
ES537104A Expired ES8606304A1 (es) 1983-10-27 1984-10-26 Un procedimiento para preparar derivados de tiazina

Country Status (21)

Country Link
US (1) US4649139A (es)
EP (1) EP0142306A3 (es)
JP (1) JPS60109577A (es)
KR (1) KR890000991B1 (es)
AU (1) AU564667B2 (es)
CA (1) CA1261328A (es)
DD (1) DD224033A5 (es)
DK (1) DK512184A (es)
ES (1) ES8606304A1 (es)
FI (1) FI844212L (es)
GB (1) GB8328757D0 (es)
GR (1) GR80723B (es)
HU (1) HU191566B (es)
IL (1) IL73332A (es)
MC (1) MC1628A1 (es)
NZ (1) NZ210000A (es)
PH (1) PH21926A (es)
PL (1) PL144899B1 (es)
PT (1) PT79416B (es)
SU (1) SU1371500A3 (es)
ZA (1) ZA848388B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8613183D0 (en) * 1986-05-30 1986-07-02 Wellcome Found Triazine salt
GB9012312D0 (en) * 1990-06-01 1990-07-18 Wellcome Found Pharmacologically active cns compounds
GB9218113D0 (en) * 1992-08-26 1992-10-14 Lilly Industries Ltd Pharmaceutical compounds
GB9726987D0 (en) 1997-12-22 1998-02-18 Glaxo Group Ltd Compounds
AU763244B2 (en) * 2000-01-03 2003-07-17 Rpg Life Sciences Limited A process for the preparation of 6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine, commonly known as lamotrigine
IL134730A (en) * 2000-02-25 2003-10-31 Chemagis Ltd Process for preparing substituted benzoyl cyanide amidinohydrazones
EP2147679B1 (en) 2001-07-25 2014-06-25 Raptor Pharmaceutical, Inc. Compositions for blood-brain barrier transport
DK1889198T3 (da) 2005-04-28 2015-02-09 Proteus Digital Health Inc Farma-informatiksystem
GB0613836D0 (en) * 2006-07-13 2006-08-23 Univ Greenwich New medical use of triazine derivatives
WO2008036682A2 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
GB0800741D0 (en) * 2008-01-16 2008-02-20 Univ Greenwich Cyclic triazo and diazo sodium channel blockers
DK2398500T3 (da) 2009-02-20 2019-05-13 2 Bbb Medicines B V Glutathion-baseret lægemiddelafgivelsessystem
IL255113B (en) 2009-05-06 2022-09-01 Laboratory Skin Care Inc Preparations for administration through the skin that include complexes of an active substance with calcium phosphate and methods of using them
GB2471713A (en) * 2009-07-08 2011-01-12 Univ Greenwich 1,2,4-triazine derivatives and their use as sodium channel blockers
GB2471729A (en) 2009-07-08 2011-01-12 Univ Greenwich 1,2,4-triazine derivatives and their use as sodium channel blockers
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
ES2858750T3 (es) 2015-06-12 2021-09-30 Univ Greenwich Derivados de triazina como inhibidores del interferón gamma
CN109810070B (zh) * 2019-01-29 2022-03-15 太原理工大学 一种含有双酰氧基结构的三嗪酮衍生物及其制备方法和应用
GB202006080D0 (en) 2020-04-24 2020-06-10 Univ Greenwich Cytokine storm syndrome
GB202006076D0 (en) 2020-04-24 2020-06-10 Univ Greenwich Interleukin inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB759014A (en) * 1952-02-26 1956-10-10 Wellcome Found Improvements in triazines and their manufacture
BG15760A3 (bg) * 1968-06-29 1976-06-21 Неизвестен Метод за получаване на производни на 5-имино- 1, 2, 4- триазина
US3637688A (en) * 1970-01-09 1972-01-25 American Home Prod 6-(fluoro and trifluoromethyl phenyl)-3 5-diamino - 1 2 4 - triazines and substituted - 6 - phenylalkyl-3,5-diamino-1 2 4-triazines
DE2003144C3 (de) * 1970-01-24 1980-01-10 Bayer Ag, 5090 Leverkusen 5-Imino-6-alkyl-1^2,4-triazin-Derivate und Verfahren zu deren Herstellung
AU530999B2 (en) * 1979-06-01 1983-08-04 Wellcome Foundation Limited, The Substituted amino triazines and their use in treatment of cns disorders
EP0021120B1 (en) * 1979-06-01 1983-04-06 The Wellcome Foundation Limited 3,5-diamino-1,2,4-triazine derivatives, process for preparing such compounds and pharmaceutical compositions containing them
US4616014A (en) * 1981-10-22 1986-10-07 Fujisawa Pharmaceutical Co., Ltd. Triazine derivatives, and pharmaceutical compositions comprising the same

Also Published As

Publication number Publication date
DD224033A5 (de) 1985-06-26
ZA848388B (en) 1986-06-25
NZ210000A (en) 1987-08-31
PL250213A1 (en) 1985-12-03
PH21926A (en) 1988-04-08
KR850002964A (ko) 1985-05-28
DK512184D0 (da) 1984-10-26
EP0142306A3 (en) 1986-11-20
HUT36102A (en) 1985-08-28
FI844212A0 (fi) 1984-10-26
PT79416B (en) 1986-11-13
GB8328757D0 (en) 1983-11-30
US4649139A (en) 1987-03-10
IL73332A (en) 1988-06-30
SU1371500A3 (ru) 1988-01-30
JPS60109577A (ja) 1985-06-15
MC1628A1 (fr) 1985-09-26
PT79416A (en) 1984-11-01
IL73332A0 (en) 1985-01-31
ES8606304A1 (es) 1986-04-16
HU191566B (en) 1987-03-30
FI844212L (fi) 1985-04-28
AU3475884A (en) 1985-05-09
GR80723B (en) 1985-02-07
AU564667B2 (en) 1987-08-20
KR890000991B1 (ko) 1989-04-15
CA1261328A (en) 1989-09-26
PL144899B1 (en) 1988-07-30
DK512184A (da) 1985-04-28
EP0142306A2 (en) 1985-05-22

Similar Documents

Publication Publication Date Title
ES554546A0 (es) Un procedimiento para preparar derivados de guanina
ES539563A0 (es) Un procedimiento para preparar derivados de fenilamino-mer- captoimidazol
ES542051A0 (es) Un procedimiento para preparar derivados de benzoilurea
ES538190A0 (es) Un procedimiento para preparar derivados de pirimidina
ES537104A0 (es) Un procedimiento para preparar derivados de tiazina
ES534694A0 (es) Un procedimiento para preparar cefuroxima sodica
ES530024A0 (es) Un procedimiento para preparar derivados de pirazinona
ES545347A0 (es) Un procedimiento para preparar derivados de pirimidina
ES533842A0 (es) Un procedimiento para la obtencion de derivados de amino-pirimidina
ES528304A0 (es) Un procedimiento para preparar derivados de pirimidona
ES534297A0 (es) Un procedimiento para preparar derivados de cefem
ES548409A0 (es) Un procedimiento para preparar derivados de bencimidazol
ES535568A0 (es) Un procedimiento para preparar derivados de piridazinona
ES531550A0 (es) Procedimiento para preparar un fenilaminobencoalcanol
ES547419A0 (es) Un procedimiento para preparar derivados de pirimidina
ES536050A0 (es) Un procedimiento para preparar fenil-carbamatos sustituidos
ES534170A0 (es) Un procedimiento para preparar 1-piridil-alquil-4-aril-piperazinas
ES552911A0 (es) Un procedimiento para preparar derivados de 3-carbonil-1-aminoalquil-1h-indol
ES538072A0 (es) Un procedimiento para preparar un difenil-eter
ES531851A0 (es) Un procedimiento para preparar derivados de morfolina
ES536293A0 (es) Un procedimiento para producir derivados de acilindol
ES546690A0 (es) Un procedimiento para preparar derivados de azirino-pirrolo-indoldiona
ES547458A0 (es) Un procedimiento para preparar derivados de piridiloxi
ES538036A0 (es) Un procedimiento para preparar derivados de piridona.
ES526177A0 (es) Un procedimiento para preparar derivados de pirimidona